Behaivior
Developing a platform to predict and prevent opioid addiction relapses and overdoses through wearables and AI.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
$800k | Grant | ||
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | - | 69 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Behaivior is a digital therapeutics company specializing in behavioral health technology to prevent relapse and overdose. The company operates in the healthcare sector, focusing on individuals undergoing recovery from substance abuse. Behaivior's core product involves wearable technology that monitors behavioral health indicators and provides real-time interventions to help individuals stay on track with their recovery process. This technology also aids care providers in delivering more effective and timely services to their clients. The business model is primarily B2B, targeting healthcare providers, rehabilitation centers, and other organizations involved in addiction recovery. Revenue is generated through the sale of wearable devices and subscription-based access to their intervention platform.
Keywords: digital therapeutics, behavioral health, wearables, relapse prevention, overdose prevention, real-time intervention, recovery process, healthcare, B2B, addiction recovery.